Moderna

Moderna is an American biotechnology company based in Cambridge, Massachusetts. They focus on drug discovery and development, and vaccine technologies based on messenger RNA.
As of November 2020, Moderna was valued at $35 billion, and while none of its drugs had been approved, its COVID-19 vaccine candidate was close to being authorized for mass use.
In 2023 it is to build a centre in Harwell, Oxfordshire, to produce vaccines for Covid, flu and respiratory syncytial virus.